ReviewBiomedicines2025
Liver Machine Perfusion: Past, Present and Future Directions.
Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).Artificial organs · 2026Article
- Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review.Journal of clinical medicine · 2026Review
- Machine Perfusion Across Marginal Liver Grafts: Benefits and Challenges.Journal of personalized medicine · 2026Review
- Endothelial-Related Gene Expression Plays a Role Against Acute Kidney Injury and Prolonged Intensive Care Stay in Liver Allografts Treated with Hypothermic Oxygenated Perfusion.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver transplantation represents the only curative method for end-stage liver disorders and certain liver malignancies. Over the last three decades, advancements in immunosuppression, surgical technique, and intensive care measures have resulted in improved patient and graft survival outcomes, but a deficit of donor organs is constantly the major issue that limits our ability to reduce the mortality on the liver transplant waiting list. To address this, marginal grafts and those from donors after cardiac death are increasingly employed, but these strategies necessitated novel methods to improve the preservation and quality of liver grafts and the most promising one is liver machine perfusion (LMP). LMP evolved significantly in the past 10 years, and consequently, it is gradually establishing itself as a standard protocol at many transplant centers. However, many unresolved questions remain concerning the indications, types, and protocols associated with LMP. Therefore, continuous research is necessary to determine optimal guidelines and recommendations for its clinical application. This review aims to analyze the development of liver machine perfusion, including its different modalities underlying mechanisms of operation, and provide an overview of its historical evolution, current status, and future prospects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.